Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2024-12-30 00:00:00 ET · period of report 2024-12-27 · accession 0001628280-24-052592 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-30 | 2024-12-27 | ARWR | OLUKOTUN ADEOYE Y | Dir | S - Sale | $20.00 | -2,850 | 36.7K | -7% | -$57.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-27 | S | D | 2,850 | $20.00 | 36,740 | D | — | — | (F2) Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions. |